Parental Involvement in Pain Reducing Measures

December 12, 2022 updated by: University Hospital Inselspital, Berne

Pain Responses in Preterm Infants and Parental Stress Over Repeated Painful Procedures: a Randomized Pilot Trial.

This pilot study was conceptualised to determine the feasibility of involving parents via facilitated tucking or observing during painful procedures and to measure change in parental stress and infant pain. An additional purpose of this pilot study was to determine the size of the cohort of preterm infants needed for a larger trial, the time, and resources required for recruitment and data collection.

Study Overview

Detailed Description

Objectives

In this pilot study, the aims were to determine the feasibility of whether pain behaviour in extremely and very preterm infants and perceived parental stress change when parents are involved in pain reducing measures, either actively, performing facilitated tucking or passively, observing the intervention, in comparison to the involvement of nurses only. In addition, the infant's pain reactivity and parental stress over three time points of measurement was of interest.

Methods

Extremely and very preterm infants in need of subcutaneous erythropoietin were randomly assigned to the two intervention groups. The intervention encompassed that one parent of each infant was involved during the painful procedure: Either parents executed facilitated tucking themselves or stood by, observing the procedure. Usual care involved that nurse executed facilitated tucking. All infants received 0.5ml of 30% oral glucose solution via cotton swab before the painful procedure. Infant pain was observed with the Bernese Pain Scale for Neonates (BPSN) and measured with the skin conductance algesimeter (SCA) before, during, and after the procedure. Parents' stress levels were measured before and after the painful procedure on the infant, using the Current Strain Short Questionnaire (CSSQ).

Feasibility of a subsequent trial was determined by assessing recruitment, measurement and active parental involvement. Quantitative data collection methods (i.e., questionnaires, algesimeter) were employed to determine the number of participants for a larger trial and measurement adequacy. Qualitative data (interviews) was employed to determine parents' perspectives of their involvement.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Premature infants born at the NICU concerned
  • Born between 24 0/7- 32 0/7 weeks of gestation, birthweight (bw) <1250g
  • Infant in need of s.c. erythropoietin
  • Parents fluently speaking and writing in German
  • Written informed consent by parents

Exclusion Criteria:

  • Premature infant with an umbilical artery pH measurement <7.00 or asphyxia
  • Premature infant with life threatening malformations of the central nervous system
  • Premature infant with intracranial haemorrhage (even if not present at the start of the study)
  • Premature infant with any surgical intervention
  • Parents with substance abuse (i.e., methadone, heroin, etc.), as mentioned in the electronic patient documentation (EPD)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Two nurses executing facilitated tucking (FT)
Usual care
Active Comparator: One parent watching passively
One parent watching passively the 2 nurses executing FT
One parent watching a procedural painful intervention, two nurses executing facilitated tucking
Active Comparator: One parent actively involved
One parent actively executing FT
One parent watching a procedural painful intervention and at the same time executing facilitated tucking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The main objective of this pilot study was to determine the feasibility of a larger, appropriately powered study
Time Frame: 1 year
Feasibility assessment included recruitment rate (dependent on resources and in-/exclusion criteria)
1 year
Percentage of questionnaire completion
Time Frame: 1 year
  • Check percentage of questionnaires completed and withdrawals
  • Interview parents about the feasibility of participating three times
1 year
The pain and stress measurement over three time points were reviewed for feasibility
Time Frame: 1 year
-The research team was also interviewed about acceptance, applicability and feasibility of the validated BPSN, the SCA over three time points
1 year
The active parental involvement over three time points were reviewed for feasibility
Time Frame: 1 year

In semi-structured interviews, parents were asked about performing facilitated tucking or standing by as observers, acceptance, applicability and feasibility of the CSSQ and measurement over three time-points

-The research team was also interviewed about active parental involvement

1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The secondary interest of the study was to test for significant differences in parental stress between the two intervention and control group at three measurement points as well as infant pain.
Time Frame: 1 year

To determine infant pain, two research team nurses observed the infant by using the Bernese Pain Scale for Neonates (BPSN) in real time before (2-3 minutes), during and (2-3 and 10 minutes) after the s.c. injection. The two nurses independently assessed the physiological and behavioural pain items [(18)]. The BPSN is a multidimensional tool in German and has shown satisfactory psychometric properties among preterm and term infants (validity: r = 0.75; reliability: α=0.8) [(18)].

Skin Conductance Algesimeter (SCA) was installed before the s.c. injection until the last BPSN measurement. An electrocardiogram electrode (ECG) was placed on the sole of the foot to the left and right of the ankle of the preterm infant. An initial baseline was obtained. Subsequently, SCA pain measurement was continuous.

1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sandra Zwakhalen, Prof. Dr., Fac. Health, Medicine and Life Sciences, Health Services Research CAPHRI - University of Maastricht

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

November 1, 2020

Study Completion (Actual)

November 1, 2022

Study Registration Dates

First Submitted

November 30, 2022

First Submitted That Met QC Criteria

December 12, 2022

First Posted (Actual)

December 19, 2022

Study Record Updates

Last Update Posted (Actual)

December 19, 2022

Last Update Submitted That Met QC Criteria

December 12, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Data collection of pain assessment

IPD Sharing Time Frame

1year

IPD Sharing Access Criteria

Personal request

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Infants

Clinical Trials on Passive parental involvement

Subscribe